Cargando…
Impact of medication adherence to dual antiplatelet therapy on the long-term outcome of drug-eluting or bare-metal stents
BACKGROUND: In percutaneous coronary intervention, drug-eluting stent (DES) showed better clinical outcome compared to bare-metal stent (BMS) but mostly with different DAPT durations. HYPOTHESIS: The clinical superiority of DES over BMS may depend on the medication adherence to dual antiplatelet the...
Autores principales: | Choi, Jung Min, Lee, Seung-Hwa, Kang, Mira, Choi, Jin-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743933/ https://www.ncbi.nlm.nih.gov/pubmed/33326492 http://dx.doi.org/10.1371/journal.pone.0244062 |
Ejemplares similares
-
Very Late Thrombosis of a Drug-Eluting Stent After Discontinuation of Dual Antiplatelet Therapy in a Patient Treated With Both Drug-Eluting and Bare-Metal Stents
por: Kim, Sung Soo, et al.
Publicado: (2009) -
Long-term clinical outcomes of drug-eluting stents vs. bare-metal stents in Chinese geriatric patients
por: Chan, Pak-Hei, et al.
Publicado: (2013) -
Very Long-term Safety and Effectiveness of Drug-Eluting or Bare-Metal Stents for Left Main Coronary Disease
por: Park, Hanbit, et al.
Publicado: (2021) -
Lesion Length Impacts Long Term Outcomes of Drug-Eluting Stents and Bare Metal Stents Differently
por: Chang, Shang-Hung, et al.
Publicado: (2013) -
Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013)